Spotlight: Market Access
Welcome to The Evidence Base Spotlight on ‘Market Access’.
Read selected coverage from The Evidence Base, covering the intricate process of ensuring that medications reach the patients who need them.
For more Market Access content, click here.
The Evidence Base is media partner for the upcoming World EPA Congress (Amsterdam, The Netherlands; March 12–13, 2024). Keep up with our coverage pre-, during and post-event here, where you can also find our deep dive reports on the 2023 congress. Read here >>
Featured content
Cinderella 2: Unlocking the value chain in antibiotic development to achieve market access success
In this Guest Column, Brendan Walkden (Head of Solici – Strategic Competitive Intelligence Division of Cambridge Healthcare Research) addresses the historic challenges and explores effective strategies for achieving market access success in the development of antibiotics within the pharmaceutical industry.
Prescribing health: the vital role of the pharmaceutical sector in improving health equity
The life sciences sector has a unique opportunity to drive tractable action to reduce health inequalities. In this Guest Column, Dr Jonathan Pearson-Stuttard (LCP Health Analytics), Dr Chris Lübker (Novo Nordisk) and Thomas Holbaek (Novo Nordisk) highlight the increasing relevance of health equity to payers and HTA bodies, underscoring their critical role in shaping access to healthcare innovations.
The end for QALYs in federal US drug value assessments?
On February 7, 2024 the US House of Representatives passed new legislation banning the use of quality-adjusted life years (QALYs) in government healthcare programs, including Medicare and Medicaid. Here we discuss what this means for the QALY in the USA.
Market access and HTA – a snapshot of recent developments with Sreeram Ramagopalan
Catch up on the Guest Column from Sreeram Ramagopalan’s (Lane Clark & Peacock, UK), where he covers recent developments in market access and HTA. The Column is published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research, with summaries on The Evidence Base.
Trust, transparency, affordability: engaging patients for fair IRA drug pricing
Kistein Monkhouse, MPA, from Patient Orator and Jason Spangler MD, MPH, FACPM, from the Innovation and Value Initiative underscore the importance of meaningful patient engagement during the IRA’s implementation as a vital step towards improving health outcomes and equity for patients.
Unlocking Medical Affairs’ hidden potential: AI at the helm
Medical Affairs divisions of the pharmaceutical industry are undergoing rapid transformation and modernization. No longer considered purely disease and product specialists, Medical Affairs groups are now sitting at the intersection of curating and creating holistic evidence ecosystems that demonstrate product value and optimize market access. They are recognized as critical to both drug development and commercial product launches.
Patti’s People – Patti Peeples speaks with Sam Roberts
In this ‘Patti’s People’ episode, Patti Peeples of the The Peeples Collaborative speaks with Sam Roberts, Chief Executive, National Institute for Health and Care Excellence (NICE), UK.
Patti’s People – Patti Peeples speaks with Kimberly Westrich
In this ‘Patti’s People’ episode, Patti Peeples of the The Peeples Collaborative speaks with Kimberly Westrich, Chief Strategy Officer, National Pharmaceutical Council (NPC).
World Evidence, Pricing and Access (EPA) Congress 2024: Navigating the conference program
As the World EPA Congress 2024 approaches, here several pivotal sessions are highlighted, providing insights to help you navigate the comprehensive multi-track program. See the dedicated World EPA Congress page here >>
WEBINAR: Mastering Metrics: Tracking and Measuring Market Access Performance – VIEW ON DEMAND
Market access is the bridge between clinical and commercial functions, and plays a pivotal role in product launch. Success in market access is defined by the outcome of payer decisions – whether nationally or regionally. While measuring global market access performance has been on the agenda for some time, understanding success is becoming a priority at board and leadership level. Catch up on this webinar on demand.
Get in touch to discuss the opportunities available to share your expertise, contribute to this theme or to become a theme sponsor.
